The market attempted to recover from a massive sell-off on Thursday.
Category: healthcare
Obamacare Insurer Centene Boosts Pandemic Outlook And Focus On Health Disparities
Health insurer Centene expects the rise in unemployment amid the spread of the coronavirus strain COVID-19 to boost Medicaid and Obamacare enrollment in the coming months and increase revenue to as much as $112 billion.
83% Of Patients Had Fewer Migraine Headaches After Doing Therapy
A new study in the journal Headache found that 83% of patients who completed a short course of cognitive behavioral therapy (CBT) had fewer migraine headaches.
Preliminary Data Suggests Low-Dose Radiation May Be Successful Treatment For Severe Covid-19
Human medical trials have begun on severely ill COVID-19 patients using low-doses of radiation. The first results on a very small group at Emory University Hospital were published this week and the results were quite extraordinary.
Smoking Cigarettes (My Circumstances Made Me Do It)
Unemployment. Psychological distress. Disability. Heavy alcohol use….The greater the number of these disadvantages a person faces, the higher their risk of smoking.
$16M Healthtech Acquisition Signals Shift In Clinician-Patient Communication
In June 2020, Induction Healthcare, the group behind the Induction and MicroGuide apps, acquired fellow healthtech company Zesty, which enables integration between a hospital’s electronic patient record (EPR) and patient administration system (PAS) in …
Stock Market Rout: Here’s What Caused The Worst Sell-Off Since March
The Dow plunged 6.9%, over 1,800 points.
What’s New About Sex And Coronavirus? Here Are Updated Guidelines From NYC
The New York City Department of Health has updated their “Safer Sex and COVID-19” guidelines including recommendations about getting kinky, questions to ask, and group sex.
Coronavirus Deaths Could Spike In September After Decrease, Model Predicts
We could see “another 100,000 deaths by September,” says a Harvard expert.
Early Data From Coronavirus Vaccine Trials Are Encouraging, But There’s Still A Long Way To Go
Virologist Dave Wessner explains what we know about two promising coronavirus vaccines so far – and how much more we still need to know before they come onto the market.
